What the AI Research tells us vs what people are saying! If you read recent scientific reviews on artificial intelligence (AI) in the pharmaceutical industry, you get a clear message: AI is transforming drug discovery, clinical development, manufacturing, and safety.¹⁻⁵ If you talk to bench scientists, clinical teams, or data scientists over coffee, you often hear a more complicated story: pockets of impressive success, a lot of incremental improvements, and quite a few stall

Choosing where to set up in Europe is just the beginning. The real challenge — and the real competitive advantage — lies in finding, attracting, and retaining the right people in markets where the best talent has choices

For generations, treating cancer has relied on a pretty brutal calculus: hit the body hard and hope the cancer dies first. Traditional chemotherapy is essentially a scorched-earth strategy. It works, but at a massive cost—wrecking the heart, gut, and nervous system along with the tumour. . For decades, researchers have chased a deceptively simple question: What if we could send the drug only where it’s actually needed? Antibody-drug conjugates, or ADCs, are the most promising

For executive search firms and VC talent managers operating in life sciences, ESG has become one of the most consequential forces shaping who gets hired, who gets funded, and which organizations attract the leadership talent capable of building enduring companies.